(Q44200942)

30 November 2017

title

Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium (English)

1 reference

30 November 2017

1 reference

Enterococcus faecium

1 reference

Manjunath P Pai

1

1 reference

30 November 2017

Keith A Rodvold

2

1 reference

30 November 2017

Paul C Schreckenberger

3

1 reference

30 November 2017

Ronald D Gonzales

4

1 reference

30 November 2017

Jennifer M Petrolatti

5

1 reference

30 November 2017

John P Quinn

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

28 October 2002

1 reference

Clinical Infectious Diseases

30 November 2017

published in

1 reference

30 November 2017

volume

35

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

1269-1272

1 reference

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

30 November 2017

cites work

1 reference

Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci

21 January 2018

1 reference

Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center

21 January 2018

1 reference

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

Linezolid and reversible myelosuppression

21 January 2018

1 reference

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/344177

1 reference

30 November 2017

1 reference